Inovio Pharmaceuticals Inc., which has not yet shared the results of the phase 1 trial for its COVID-19 vaccine candidate, has already received millions of dollars in funding to expand manufacturing capacity. An announcement Tuesday that the Defense Department would pay $ 71 million to finance the manufacture of a …
Read More »